Skip to main content

Evolving Strategies for the Selection, Dereplication and Prioritization of Antitumor and HIV-Inhibitory Natural Products Extracts

  • Chapter
Bioassay Methods in Natural Product Research and Drug Development

Abstract

There is ever increasing pressure in all pharmaceutical lead discovery laboratories and programs to identify novel bioactive chemical entities more quickly and efficiently. In order to accomplish this, the process of selecting which screening leads to pursue or advance has taken center stage as the most critical task in the discovery process. In programs emphasizing natural products as a source of such lead compounds, this task is complicated by the need to differentiate activity due to: a) commonly recurring classes of “nuisance compounds”, so-called because they provide a non-specific response in a large number of bioassays; b) known secondary metabolites which may or may not occur widely, but which provide a specific response in the assay in question; and c) novel chemical entities which are specifically active in the target assay.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cardellina, J.H., II, Munro, M.H.G., Fuller, R.W., Manfredi, K.P, McKee, T.C., Tischler M., Bokesch, H.R., Gustafson K.R., Beutler, J.A. and Boyd, M.R.: A chemical screening strategy for the dereplication and prioritization of HIV-inhibitory aqueous natural products extracts. J. Nat. Prod., 56: 1123–1129, 1993.

    Article  CAS  Google Scholar 

  2. Beutler, J.A., McKee, T.C, Fuller, R.W., Tischler M., Cardellina, J.H., II, McCloud, T.G., Snader, K.M. and Boyd, M.R.: Frequent occurrence of HIV-inhibitory sulfated polysaccharides from marine invertebrates. Antiviral Chem. Chemother., 3: 167–172, 1993.

    Google Scholar 

  3. McKee, T.C, Cardellina, J.H., II, Riccio R., D’Auria, M.V., Iorizzi M., Minale L., Moran, R.A., Gulakowski, R.J., McMahon, J.B., Buckheit, R.W., Jr., Snader, K.M. and Boyd, M.R.: HIV inhibitory natural products. 11. Comparative studies of sulfated sterols from marine invertebrates. J. Med. Chem., 37: 793–797, 1994.

    Article  CAS  Google Scholar 

  4. Gustafson, K.R., Cardellina, J.H., II, Fuller, R.W., Weislow, O.S., Kiser, R.F., Snader, K.M., Patterson, G.M.L. and Boyd, M.R.: AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae). J. Natl. Cancer Inst., 16: 1254–1258, 19

    Article  Google Scholar 

  5. Tischler M., Cardellina, J.H., II, Cragg, G.M. and Boyd, M.R.: Cytotoxic quassinoids from Cedronia granatensis, Cautrec. J. Nat. Prod., 55: 667–671, 1992.

    Article  CAS  Google Scholar 

  6. Decosterd L., Gustafson, K.R., Cardellina, J.H., II, Cragg, G.M. and Boyd, M.R.: The differential cytotoxicity of cardenolides from Thevetia ahouia. Phytother. Res., 8: 74–77, 1994.

    Article  CAS  Google Scholar 

  7. Fuller, R.W., Cardellina, J.H., II, Cragg, G.M. and Boyd, M.R.: Cucurbitacins: differential cytotoxicity, dereplication and first isolation from Gonystylus keithü. J. Nat. Prod., 57: 1442–1445, 1994.

    Article  CAS  Google Scholar 

  8. Rashid, M.R., Gustafson, K.R., Cardellina, J.H., II and Boyd, M.R.: Mycalolides D and E, new cytotoxic macrolides from a collection of the stony coral Tubastrea, sp. J. Nat. Prod., 58: 1120–1125, 1995.

    Article  CAS  Google Scholar 

  9. Zabriskie, T.M., Klocke, J.A., Ireland, CM., Marcus, A.H., Molinski, T.F., Faulkner, D.J.,Xu, C and Clardy, J.C.: Jaspamide, a modified peptide from a Jaspis, sponge, with insecticidal and antifungal activity. J.Am.Chem.Soc., 108: 3123–3124, 1986.

    Article  CAS  Google Scholar 

  10. Crews P., Manes, L.V. and Boehler, M.: Jasplakinolide, a cyclodepsipeptide from the marine sponge Jaspis, sp. Tetrahedron Lett., 27: 2797–2800, 1986.

    Article  CAS  Google Scholar 

  11. Talpir R., Benayahu Y., Kashman Y., Pannell, L. and Schleyer, M.: Hemiasterlin and geodiamolide TA; Two new cytotoxic peptides from the marine sponge Hemiasterella minor, (Kirkpatrick). Tetrahedron Lett., 35: 4453–4453, 1994.

    Article  CAS  Google Scholar 

  12. Coleman, J.E., deSilva, E.D., Kong, F. and Andersen, R.J.: Cytotoxic peptides from the marine sponge Cymbastela, sp. Tetrahedron, 51: 10653–10662, 1995.

    Article  CAS  Google Scholar 

  13. Kashman Y., Gustafson, K.R., Fuller, R.W., Cardellina, J.H., II, McMahon, J.B., Currens, M.J., Buckheit, R.W., Jr., Hughes, S.H., Cragg, G.M. and Boyd, M.R.: The calanolides, novel HIV-inhibitory coumarins from the tropical rainforest tree Calophyllum lanigerum. J. Med. Chem., 35: 2735–2742, 1992.

    Article  CAS  Google Scholar 

  14. Currens, M.J., Gulakowski, R.J., Mariner, J.M., Moran, R.A., Buckheit, R.W., Gustafson, K.R., McMahon, J.B. and Boyd, M.R.: Antiviral activity and mechanism of action of calanolide a against the Human Immunodeficiency Virus Type-1. J. Pharmacol. Exp. Ther., 279: 645–651, 1996.

    CAS  Google Scholar 

  15. Hizi A., Tal R., Shaharabany M., Currens, M.J., Boyd, M.R., Hughes, S.B. and McMahon, J.B.: Specific inhibition of the reverse transcriptase of Human Immunodeficiency Virus Type 1 and the chimeric enzymes of Human Immunodeficiency Virus Type 1 and Type 2 by nonnucleoside inhibitors. Antimicrob. Agents Chemother., 37: 1037–1042, 1993.

    Article  CAS  Google Scholar 

  16. Currens, M.J., Mariner, J.M., McMahon, J.B. and Boyd, M.R.: Kinetic analysis of inhibition of Human Immunodeficiency Virus Type-1 reverse transcriptase by calanolide A. J. Pharmacol. Exp. Ther., 279: 652–661, 1996.

    CAS  Google Scholar 

  17. Gustafson, K.R., Blunt, J.W., Munro, M.H.G., Fuller, R.W., McKee, T.C., Cardellina, J.H., II, McMahon, J.B., Cragg, G.M. and Boyd, M.R.: The guttiferones, HIV-inhibitory benzophenones from Symphonia globulifera, Garcinia livingstonei, Garcinia ovalifolia, and Clusia rosea. Tetrahedron, 48: 10093–10102, 1992.

    Article  CAS  Google Scholar 

  18. Ormancey-Poitier A., Buzas, A. and Lederer, E.: Calophyllolide and calophylic acid from the seeds of Calophyllum inophyllum. Bull. Soc. Chem., Fr. 577–580, 1951.

    Google Scholar 

  19. Monache, G.D., Gonzalez, J.G., Monache, F.D. and Bettolo, G.B.M.: Prenylated benzophenones from Vísmia decipiens. Phytochemistry, 19: 2025–2028, 1980.

    Article  Google Scholar 

  20. Pathak, V.P., Khanna, R.N.: vismiaphenone B and isovismiaphenone B. Bull. Chem. Soc. Jpn., 55: 2264–2266, 1982.

    Article  CAS  Google Scholar 

  21. Moore, R.E. and Scheuer, P.J.: Palytoxin: A new marine toxin from a coelenterate. Science, 172: 495–498, 1971.

    Article  CAS  Google Scholar 

  22. Moore, R.E. and Bartolini, G.: Structure of palytoxin. J. Am. Chem. Soc., 103: 2491–2494, 1981.

    Article  CAS  Google Scholar 

  23. Usami, M.; Satake, M.; Ishida, S.; Inoue, A.; Kan, Y. and Yasumoto, T: Palytoxin analogs from the dinoflagellate Ostreopsis siamensis. J. Am. Chem. Soc., 117: 5389–5390, 1995.

    Article  CAS  Google Scholar 

  24. Matsunaga S., Fusetani N., Hashimoto K., Koseki K., Noma M., Noguchi, H. and Sankawa, U.: Further kabiramides and halichondramides, cytotoxic macrolides embracing trisoxazole, from the Hexabranchus egg masses. J. Org. Chem., 54: 1360–1363, 1989.

    Article  CAS  Google Scholar 

  25. Matsunaga S., Fusetani N., Hashimoto K., Koseki, K. and Noma, M.: Kabiramide C, a novel antifungal macrolide from nudibranch egg masses. J. Am. Chem. Soc., 108: 247–849,1986.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Cardellina, J.H. et al. (1999). Evolving Strategies for the Selection, Dereplication and Prioritization of Antitumor and HIV-Inhibitory Natural Products Extracts. In: Bohlin, L., Bruhn, J.G. (eds) Bioassay Methods in Natural Product Research and Drug Development. Proceedings of the Phytochemical Society of Europe, vol 43. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4810-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-4810-8_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6019-6

  • Online ISBN: 978-94-011-4810-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics